ProKidney (PROK) via Social Capital Suvretta III (DNAC) deck
ProKidney is a leading clinical-stage cellular therapeutics company focused on chronic kidney disease.
![](/content/images/size/w1304/2022/01/g281485ex99_2s1g1-1.jpg)
ProKidney is a leading clinical-stage cellular therapeutics company focused on chronic kidney disease.